Lars Fruergaard Jørgen
Lars Fruergaard Jørgen is the former CEO of Novo Nordisk, a leading Danish pharmaceutical company known for its groundbreaking weight-loss medications such as Ozempic and Wegovy. He stepped down in May 2023 amid a significant decline in the company's stock value, which had dropped over 50% in the previous year, due to increased competition and pressures on profit margins.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 3.00 | 0.06% | +0% | 60,461,826 | 34,373 | $2,000,000 | 1,137$ |
| Totals | 1 | 60,461,826 | 34,373 | $2,000,000 | 1,137$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Lars Fruergaard Jørgen announced his resignation as CEO of Novo Nordisk amid a significant drop in the company's stock value.
3